<p>Mountaineers experiencing high altitude sickness have traces of bleeding in the brain years after the incident, say a new study. High altitude cerebral edema (HACE) is a severe and often fatal condition that can affect mountain climbers, hikers, skiers and travellers at high altitudes - typically above 7,000 feet, or 2,300 meters. <br /><br />HACE results from swelling of brain tissue due to leakage of fluids from the capillaries. Symptoms include headache, loss of coordination and decreasing levels of consciousness.<br /><br />“HACE is a life-threatening condition,” said Michael Knauth, neuroradiologist from the University Medical Centre, Goettingen, Germany. </p>.<p>“It usually happens in a hostile environment where neither help nor proper diagnostic tools are available.”<br /><br />Knauth and colleagues at the University Hospitals in Goettingen and Heidelberg, compared brain MRI findings among four groups of mountaineers: climbers with well documented episodes of HACE; climbers with a history of high altitude illness; climbers with a history of severe acute mountain sickness (AMS).<br /><br />And lastly climbers with a history of isolated high altitude pulmonary edema (HAPE), a life-threatening accumulation of fluid in the lungs that occurs at high altitudes, according to University Medical Centre statement. <br /><br />Two neuroradiologists assessed the brain MRI findings without knowing the status of the mountaineers and assigned a score based on the number and location of any microhemorrhages.<br /><br />“In most cases, these microhemorrhages are so small that they are only visible with a special MRI technique called susceptibility-weighted imaging,” Knauth said. “With this technique, the microhemorrhages are depicted as little black spots.”</p>
<p>Mountaineers experiencing high altitude sickness have traces of bleeding in the brain years after the incident, say a new study. High altitude cerebral edema (HACE) is a severe and often fatal condition that can affect mountain climbers, hikers, skiers and travellers at high altitudes - typically above 7,000 feet, or 2,300 meters. <br /><br />HACE results from swelling of brain tissue due to leakage of fluids from the capillaries. Symptoms include headache, loss of coordination and decreasing levels of consciousness.<br /><br />“HACE is a life-threatening condition,” said Michael Knauth, neuroradiologist from the University Medical Centre, Goettingen, Germany. </p>.<p>“It usually happens in a hostile environment where neither help nor proper diagnostic tools are available.”<br /><br />Knauth and colleagues at the University Hospitals in Goettingen and Heidelberg, compared brain MRI findings among four groups of mountaineers: climbers with well documented episodes of HACE; climbers with a history of high altitude illness; climbers with a history of severe acute mountain sickness (AMS).<br /><br />And lastly climbers with a history of isolated high altitude pulmonary edema (HAPE), a life-threatening accumulation of fluid in the lungs that occurs at high altitudes, according to University Medical Centre statement. <br /><br />Two neuroradiologists assessed the brain MRI findings without knowing the status of the mountaineers and assigned a score based on the number and location of any microhemorrhages.<br /><br />“In most cases, these microhemorrhages are so small that they are only visible with a special MRI technique called susceptibility-weighted imaging,” Knauth said. “With this technique, the microhemorrhages are depicted as little black spots.”</p>